Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer
NCT06161428 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-12-13
Summary
The aim of the study is to evaluate the feasibility of applying the SLN mapping technique in combination with FDG-PET/CT imaging in women with vulva cancer tumour size \>4 cm, multifocal tumors and local recurrences.
Conditions
- Vulva Cancer
- Sentinel Lymph Node
Sponsors & Collaborators
-
Aarhus University Hospital
collaborator OTHER -
Rigshospitalet, Denmark
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-01
- Primary Completion
- 2026-07-01
- Completion
- 2027-07-01
Countries
- Denmark
Study Locations
More Related Trials
-
Radiochemotherapy and Interventional Radiotherapy in Vaginal Cancer
NCT06314568 ·Status: RECRUITING
-
A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer
NCT04974827 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
NCT06288373 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
SUV Max as Predictor of Outcome in Cervical Cancer
NCT01262144 ·Status: COMPLETED
-
Individualized Precise Radiotherapy With the Guidance of Radiosensitivity of Locally Advanced Cervical Cancer
NCT03163979 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
NCT06079671 ·Status: RECRUITING ·Phase: PHASE3
-
Multicenter Phase II Study of Sentinel Node Detection in Squamous Cell Carcinoma T1-T2N0 of the Oropharynx Treated With Radiotherapy and Larynx Treated by Surgery, Laser or Robot
NCT03010553 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer
NCT06292689 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase II Study of Extended Field IMRT External Beam Irradiation and Intracavitary Brachytherapy
NCT00590967 ·Status: TERMINATED ·Phase: PHASE2
-
Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer
NCT04070976 ·Status: RECRUITING ·Phase: NA
-
Detection of Circulating Tumor DNA in p16- Locally Advanced Head Neck Squamous Cell Carcinoma
NCT03896412 ·Status: COMPLETED ·Phase: NA
-
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
NCT04333537 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Cisplatin+Pembrolizumab+RT in Vulvar Cancer
NCT04430699 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
NCT07061977 ·Status: RECRUITING ·Phase: PHASE3
-
Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery
NCT04169763 ·Status: RECRUITING ·Phase: PHASE1
-
A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients
NCT01755897 ·Status: COMPLETED ·Phase: NA
-
Assessment Study to Evaluate Specific Immune Response in Locally Advanced Cervix Cancer After Radio-chemotherapy
NCT03255252 ·Status: TERMINATED ·Phase: PHASE2
-
Sentinel NOSE Study: Prospective Registration Study on the Sentinel Node Procedure for Bulky Squamous Cell Carcinoma of the Nasal Vestibule.
NCT05637307 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer
NCT02467907 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
NCT00462397 ·Status: UNKNOWN ·Phase: PHASE2
-
The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.
NCT04403867 ·Status: RECRUITING
-
Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors
NCT06727617 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer
NCT05179317 ·Status: UNKNOWN ·Phase: PHASE2
-
Adjuvant Chemotherapy for Locally Advanced Cervical Cancer
NCT02036164 ·Status: UNKNOWN ·Phase: PHASE3
-
NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Cervical Cancer FIGO Stage IB2 and IIB
NCT02422563 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3